Small study links prenatal antidepressants to infant brain changes

05/27/2014 | Medscape (free registration)

Infants whose mothers took selective serotonin reuptake inhibitors during pregnancy to treat depression had a higher risk of having Chiari type I brain malformation compared with those not exposed to the drugs, according to a small study in Neuropsychopharmacology. Prenatal exposure to SSRIs was also associated with shorter length, earlier birth and longer stays in neonatal intensive care units.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ